# Tranexamic Acid for Total Knee Arthroscopy

> **NCT04443920** · PHASE4 · COMPLETED · sponsor: **The Miriam Hospital** · enrollment: 86 (actual)

## Conditions studied

- Blood Loss, Surgical

## Interventions

- **DRUG:** Tranexamic acid (TXA)
- **DRUG:** Placebo Normal Saline (NS)

## Key facts

- **NCT ID:** NCT04443920
- **Lead sponsor:** The Miriam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-29
- **Primary completion:** 2020-10-07
- **Final completion:** 2021-01-08
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04443920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04443920, "Tranexamic Acid for Total Knee Arthroscopy". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT04443920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*